A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age



Status:Recruiting
Conditions:Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:Any
Updated:3/27/2019
Start Date:January 21, 2019
End Date:May 30, 2021
Contact:Study Contact
Email:JNJ.CT@sylogent.com
Phone:844-434-4210

Use our guide to learn which trials are right for you!

A Randomized, Controlled, Observer-blind, Phase 1/2a Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers 12 to 24 Months of Age

The purpose of this study is to assess the safety and reactogenicity of an intramuscular
regimen of 3 doses of 2.5*10^10 viral particles (vp) of adenovirus serotype 26 based
respiratory syncytial virus pre-fusion protein (Ad26.RSV.preF) vaccine in RSV-seronegative
toddlers aged 12 to 24 months.


Inclusion Criteria:

- Participant who is seronegative for respiratory syncytial virus (RSV) within 42 days
prior to dosing

- Participant is the product of a normal term pregnancy greater than or equal to (>=)37
weeks, with a minimum birth weight of 2.5 kilogram (kg)

- Participant must be in good health without any significant medical illness on the
basis of physical examination, medical history, and vital signs performed at screening

- Participant has received all routine immunizations appropriate for his or her age
according to local guidelines

- Each participant's parent(s)/legal guardian(s) must have access to a consistent means
of contact either by telephone contact or email/computer

Exclusion Criteria:

- Participant's weight is below tenth percentile according to World Health Organization
(WHO) pediatric growth and weight charts

- Participant has any clinically significant acute or chronic medical condition (for
example, history of seizure disorders, bleeding/clotting disorder, autoimmune disease,
active malignancy, systemic infections, congenital heart disease, history of any
pulmonary condition requiring medication, atopy, reactive airway disease,
medically-confirmed wheezing, bronchoconstriction or treatment with a beta 2 agonist,
cystic fibrosis, bronchopulmonary dysplasia, chronic pulmonary disease,
medically-confirmed apnea, hospitalization for respiratory illness, or mechanical
ventilation for respiratory illness) that, in the opinion of the investigator, would
preclude participation

- Participant is in receipt of, or planning to receive, live attenuated vaccine (for
example, measles, mumps and rubella [MMR] or varicella, but excluding rotavirus
vaccine) within 28 days of each study vaccination (that is, before and after); other
vaccines (for example, influenza, pertussis, polio or rotavirus) should be given at
least 14 days before or 14 days after each study vaccination

- Participant has known or suspected immunodeficiency, such as known human
immunodeficiency virus (HIV) infection

- Participant has a known allergy to vaccines or vaccine components (including any of
the constituents of the study vaccine), or history of anaphylaxis or other serious
adverse reactions to vaccines or vaccine components (including any of the constituents
of the study vaccine). Participants with egg allergies can be enrolled
We found this trial at
8
sites
Newton, Kansas 67114
?
mi
from
Newton, KS
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dakota Dunes, South Dakota 57049
?
mi
from
Dakota Dunes, SD
Click here to add this to my saved trials
Geelong,
?
mi
from
Geelong,
Click here to add this to my saved trials
Jefferson City, Tennessee 37760
?
mi
from
Jefferson City, TN
Click here to add this to my saved trials
2401 Gillham Road
Kansas City, Missouri 64108
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
?
mi
from
Omaha, NE
Click here to add this to my saved trials
2500 California Plaza
Omaha, Nebraska 68102
(402) 280-2700
Creighton University Creighton University, located in Omaha, Neb., offers a top-ranked education in the Jesuit...
?
mi
from
Omaha, NE
Click here to add this to my saved trials